The AHA today urged the Centers for Medicare & Medicaid Services to increase the number of hospital-based and physician office laboratories that qualify as applicable laboratories under its proposed rule for the new Clinical Laboratory Fee Schedule to ensure its rates are representative of overall market rates. “[T]he AHA is concerned that, under CMS’s proposed [Tax Identification Number]-level definition, virtually no hospital-based laboratories and only 4 percent of physician office laboratories would qualify as applicable laboratories,” AHA Executive Vice President Tom Nickels wrote. “...Therefore, the weighted median CLFS payment rates would be dominated and driven by payment data submitted primarily by the large independent laboratories – and not actually market based.” AHA also urged CMS to delay implementation of the new payment system until at least 2018 to allow the agency more time to issue guidance on data collection and reporting and engage in end-to-end testing. “Reporting data in the absence of a final rule and comprehensive guidance based on the policies described in the final rule exposes laboratories to compliance risks and enforcement penalties, including civil monetary penalties of up to $10,000 per day for each failure to report or each misrepresentation or omission,” Nickels wrote. AHA also commented on the definition of an advanced diagnostic laboratory test and coding for ADLTs and other clinical tests.

Related News Articles

Perspective
Public
Congress returns to Washington, D.C., this week facing a long list of things to do, including several that will impact hospitals’ ability to provide access to…
Headline
The Department of Health and Human Services Sept. 4 announced new hardship exemption guidance that would allow consumers ineligible for premium tax credits or…
Headline
The AHA Sept. 4 expressed support for the Hospitals As Naloxone Distribution Sites Act (H.R. 5120), legislation that would require Medicare and Medicaid to…
Headline
The Cybersecurity and Infrastructure Security Agency, National Security Agency and international agencies Sept. 3 released joint guidance outlining a “software…
Headline
The Food and Drug Administration has identified Class I recalls for the following products due to the potential for serious injury or death:Certain lots of…
Headline
The Department of Health and Human Services Sept. 3 announced it will increase resources to curb information blocking and take action against health care…